| Literature DB >> 35733805 |
Guojun Liu1, Xiaoying Zhang1, Xiaoning Huo1, Wei Li2,3.
Abstract
Aims: The purpose of this study was to investigate the prevalence, influencing factors, and clinical characteristics of cognitive impairment in elderly patients with chronic schizophrenia. Materials andEntities:
Keywords: MMSE; chronic schizophrenia; cognitive impairment; elderly; hobby
Year: 2022 PMID: 35733805 PMCID: PMC9207234 DOI: 10.3389/fpsyt.2022.910814
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 5.435
FIGURE 1Research flow chart of whole study.
Demographic, clinical, and cognitive characteristics in chronic elderly schizophrenia with or without cognitive impairment.
| Characteristics | Whole sample ( | Cognitive impairment ( | Cognitively normal ( | |
| Age, years (SD) | 67.15 (6.62) | 67.14 (6.95) | 66.22 (5.25) | 0.391 |
| Education, years (SD) | 8.15 (3.70) | 7.91 (3.92) | 8.97 (2.63) | 0.308 |
| Course of disease, years (SD) | 36.34 (12.61) | 36.61 (12.61) | 35.40 (12.65) | 0.288 |
| The onset age, years (SD) | 30.76 (12.60) | 30.73 (12.74) | 30.86 (12.24) | 0.865 |
| Albumin, g/L (SD) | 40.51 (4.28) | 40.46 (4.35) | 40.69 (4.09) | 0.991 |
| Triglycerides, mmol/L (SD) | 1.40 (0.81) | 1.36 (0.76) | 1.55 (0.96) | 0.226 |
| Total cholesterol, mmol/L (SD) | 4.75 (1.00) | 4.70 (0.98) | 4.94 (1.06) | 0.355 |
| High density lipoprotein, mmol/L (SD) | 1.33 (0.43) | 1.34 (0.43) | 1.31 (0.43) | 0.595 |
| Low density lipoprotein, mmol/L (SD) | 2.76 (0.76) | 2.73 (0.74) | 2.87 (0.82) | 0.603 |
| Fasting plasma glucose, mmol/L (SD) | 5.43 (1.28) | 5.45 (1.31) | 5.36 (1.18) | 0.952 |
| Body mass index, kg/m2 (SD) | 23.94 (4.06) | 23.86 (4.14) | 24.25 (3.80) | 0.523 |
| Male, | 140 (53.0) | 108 (52.7) | 32 (54.2) | 0.883 |
| Hypertension, | 94 (35.6) | 77 (37.6) | 17 (28.8) | 0.280 |
| Diabetes, | 65 (24.6) | 51 (24.9) | 14 (23.7) | 1.000 |
| Hyperlipidemia, | 97 (36.7) | 72 (35.1) | 25 (42.4) | 0.358 |
| Smoker, | 96 (36.4) | 70 (34.1) | 26 (44.1) | 0.170 |
| Drinker, | 32 (12.1) | 23 (12.1) | 9 (15.3) | 0.376 |
| Take exercise, | 95 (36.0) | 66 (32.2) | 29 (49.2) | 0.021 |
| Hobby, | 108 (40.9) | 67 (32.7) | 41 (69.5) | < 0.001 |
| Atypical antipsychotics, | 159 (62.4) | 118 (59.9) | 41 (70.7) | 0.166 |
| GDS | 10.10 (5.89) | 10.67 (5.96) | 8.37 (5.37) | 0.008 |
| MMSE | 18.98 (7.88) | 16.62 (7.40) | 27.19 (1.09) | < 0.001 |
| ADL | 27.19 (11.31) | 29.63 (11.41) | 19.03 (5.90) | < 0.001 |
| PANSS | ||||
| Positive symptom scale | 12.13 (6.05) | 12.31 (6.06) | 11.53 (6.02) | 0.237 |
| Negative symptom scale | 18.42 (8.37) | 19.45 (8.57) | 15.03 (6.71) | < 0.001 |
| General condition scale | 32.92 (10.71) | 33.86 (11.10) | 29.81 (8.71) | 0.003 |
| Total score scale | 63.91 (21.39) | 66.01 (21.71) | 56.97 (18.85) | < 0.001 |
*, p < 0.05; MMSE, Mini-mental State Examination; MoCA, Montreal Cognitive Assessment; GDS, Geriatric Depression Scale; ADL, Activity of Daily Living Scale; PANSS, Positive And Negative Syndrome Scale.
Binary logistic regression analyses for factors related to cognitive impairment in chronic elderly schizophrenia.
| Variables | B | S.E | Wals | df |
| OR | 95% confidence interval |
|
| |||||||
| Take exercise | –0.129 | 0.337 | 0.146 | 1 | 0.702 | 0.879 | 0.454–1.703 |
| Hobby | –1.495 | 0.345 | 18.780 | 1 | < 0.001 | 0.224 | 0.114–0.441 |
|
| |||||||
| Take exercise | 0.015 | 0.362 | 0.002 | 1 | 0.966 | 1.015 | 0.500–2.064 |
| Hobby | –0.900 | 0.374 | 5.782 | 1 | 0.016 | 0.406 | 0.195–0.847 |
| GDS | –0.076 | 0.030 | 6.362 | 1 | 0.012 | 0.927 | 0.873–0.983 |
| ADL | –0.099 | 0.024 | 17.206 | 1 | < 0.001 | 0.906 | 0.864–0.949 |
| PANSS | –0.011 | 0.011 | 1.034 | 1 | 0.309 | 0.989 | 0.969–1.010 |
*, p < 0.05; MMSE, Mini-mental State Examination; GDS, Geriatric depression scale; ADL, Activity of Daily Living Scale; PANSS, Positive And Negative Syndrome Scale.Model
FIGURE 2Receiver operating characteristic to curve to investigate the accuracy of hobbies in diagnosing cognitive impairment.
FIGURE 3Mediating effect model among hobbies, PANSS, and MMSE score. *, p < 0.05; MMSE, Mini-mental State Examination; PANSS, Positive and Negative Syndrome Scale.
Demographic, clinical, and cognitive characteristics in normal elderly with or without cognitive impairment.
| Characteristics | Whole sample ( | Cognitive impairment ( | Cognitively normal ( | |
| Age, years (SD) | 69.84 (7.61) | 72.04 (9.19) | 69.40 (7.21) | 0.451 |
| Education, years (SD) | 9.77 (4.01) | 7.38 (4.66) | 10.25 (3.71) | 0.022 |
| Triglycerides, mmol/L (SD) | 1.93 (1.45) | 1.55 (1.15) | 2.01 (1.50) | 0.226 |
| Total cholesterol, mmol/L (SD) | 4.94 (1.08) | 4.87 (1.00) | 4.95 (1.05) | 0.715 |
| High density lipoprotein, mmol/L (SD) | 1.19 (0.27) | 1.25 (0.35) | 1.17 (0.25) | 0.152 |
| Low density lipoprotein, mmol/L (SD) | 2.93 (0.84) | 3.02 (0.81) | 2.91 (0.85) | 0.560 |
| Fasting plasma glucose, mmol/L (SD) | 5.44 (1.45) | 5.24 (1.29) | 5.49 (1.49) | 0.163 |
| Body mass index, kg/m2 (SD) | 24.15 (3.38) | 23.30 (2.92) | 24.33 (3.45) | 0.484 |
| Male, | 61 (39.1) | 8 (30.8) | 53 (40.8) | 0.386 |
| Hypertension, | 79 (50.6) | 16 (61.5) | 63 (48.5) | 0.284 |
| Diabetes, | 15 (9.6) | 2 (7.7) | 13 (10.0) | 1.000 |
| Hyperlipidemia, | 26 (18.1) | 6 (25.0) | 20 (16.7) | 0.297 |
| Smoker, | 35 (22.4) | 5 (19.2) | 30 (23.1) | 0.800 |
| Drinker, | 30 (19.4) | 3 (11.5) | 27 (20.9) | 0.414 |
| Take exercise, | 100 (65.8) | 19 (73.1) | 81 (64.3) | 0.498 |
| Hobby, | 90 (60.4) | 17 (65.4) | 73 (59.3) | 0.662 |
| GDS | 5.41 (4.34) | 5.31 (4.48) | 5.43 (4.33) | 0.895 |
| MMSE | 27.99 (2.27) | 24.47 (2.26) | 28.74 (1.37) | < 0.001 |
| ADL | 14.29 (1.97) | 14.88 (2.47) | 14.18 (1.85) | 0.095 |
*, p < 0.05; MMSE, Mini-mental State Examination; MoCA, Montreal Cognitive Assessment; GDS, Geriatric Depression Scale; ADL, Activity of Daily Living Scale.
Binary logistic regression analyses for factors related to cognitive impairment in normal elderly.
| Variables | B | S.E | Wals | df |
| OR | 95% confidence interval |
| Education | −0.165 | 0.052 | 10.106 | 1 | 0.001 | 0.848 | 0.766–0.939 |
*, p < 0.05.